![Erin Boyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erin Boyer
Human Resources Officer bij
UNIQURE N.V.
Profiel
Erin Boyer currently works at uniQure NV, as Chief People & Culture Officer from 2022.
Ms. Boyer also formerly worked at Obsidian Therapeutics, Inc., as Vice President-Human Resources, Alnylam Pharmaceuticals, Inc., as Head-Global Talent Strategy & Planning from 2017 to 2019, and Epizyme, Inc., as Chief People & Culture Officer from 2020 to 2022.
Ms. Boyer received her undergraduate degree from Macalester College.
Actieve functies van Erin Boyer
| Bedrijven | Functie | Begin |
|---|---|---|
| UNIQURE N.V. | Human Resources Officer | 01-04-2022 |
Eerdere bekende functies van Erin Boyer
| Bedrijven | Functie | Einde |
|---|---|---|
| EPIZYME, INC. | Human Resources Officer | 01-04-2022 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-09-2019 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Human Resources Officer | - |
Opleiding van Erin Boyer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Macalester College
 Macalester College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
